While the COVID-19 vaccines introduced many people to RNA-based medicines, RNA oligonucleotides have already been on the market for years to treat diseases like Duchenne Muscular Dystrophy and amyloidosis.
A better way to make RNA drugs: Enzymatic synthesis method expands capabilities while eliminating toxic byproducts retrieved 12 July 2024 from https://phys.org/news/2024-07-rna-drugs-enzymatic-synthesis-method.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.Use this form if you have come across a typo, inaccuracy or would like to send an edit request for the content on this page. For general inquiries, please use ourThank you for taking time to provide your feedback to the editors.
Your feedback is important to us. However, we do not guarantee individual replies due to the high volume of messages.to let the recipient know who sent the email. Neither your address nor the recipient's address will be used for any other purpose. The information you enter will appear in your e-mail message and is not retained by Phys.org in any form.Get weekly and/or daily updates delivered to your inbox.
Physics News Science News Technology News Physics Materials Nanotech Technology Science
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Innovative light-driven enzymatic biosystem for the synthesis of natural terpenoidsTerpenoids, such as α-farnesene, are natural compounds widely used in flavoring agents, fragrances, and even in biofuels. Traditionally, α-farnesene is extracted from plants, and hence their production may suffer from low yields and poor purity, unable to meet the criteria for human use.
Read more »
How Will Enzymatic Recycling Of Plastics Impact Your Operations And Products?I am the CEO of Everest Group, a leading research firm I founded in 1991 with headquarters in Dallas and offices around the globe.
Read more »
Revolutionary Genetics Research Shows RNA May Rule Our GenomeScientists have recently discovered thousands of active RNA molecules that can control the human body
Read more »
Non-coding RNA acts as 'superhighway' for gene expression, study findsThe function of non-coding RNA in the cell has long been a mystery to researchers. Unlike coding RNA, non-coding RNA does not produce proteins—yet it exists in large quantities.
Read more »
Researchers develop RNA-targeting technology for precisely manipulating parts of human genesResearchers at the University of Toronto have harnessed a bacterial immune defense system, known as CRISPR, to efficiently and precisely control the process of RNA splicing.
Read more »
Researchers develop RNA-targeting technology for precisely manipulating parts of human genesResearchers have harnessed a bacterial immune defense system, known as CRISPR, to efficiently and precisely control the process of RNA splicing. The technology opens the door to new applications, including systematically interrogating the functions of parts of genes and correcting splicing deficiencies that underlie numerous diseases and disorders.
Read more »